Efficacy and safety of low dose oral prednisolone as compared to pulse intravenous methylprednisolone in managing moderate severe Graves’ orbitopathy: A randomized controlled trial

BACKGROUND: High dose oral prednisolone (100 mg/day) in Graves’ orbitopathy (GO) is limited by lesser response, and greater side-effects compared to intravenous (iv) methylprednisolone. Low dose oral prednisolone has not been evaluated in GO. This study aimed to evaluate the safety and efficacy of l...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Indian J Endocrinol Metab
Main Authors: Roy, Ajitesh, Dutta, Deep, Ghosh, Sujoy, Mukhopadhyay, Pradip, Mukhopadhyay, Satinath, Chowdhury, Subhankar
Formato: Artigo
Idioma:Inglês
Publicado em: Medknow Publications & Media Pvt Ltd 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4366772/
https://ncbi.nlm.nih.gov/pubmed/25932389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.152770
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados